Genscript Biotech
1548.HK
#3647
Rank
NZ$4.95 B
Marketcap
$2.32
Share price
-1.30%
Change (1 day)
-54.18%
Change (1 year)

Revenue for Genscript Biotech (1548.HK)

Revenue in 2022: NZ$1.06 Billion

According to Genscript Biotech 's latest financial reports the company's current revenue (TTM ) is NZ$1.06 Billion. In 2022 the company made a revenue of NZ$1.06 Billion an increase over the revenue in the year 2021 that were of NZ$0.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genscript Biotech from 2014 to 2022

Annual revenue

Year Revenue Change
2022NZ$1.06 B27.67%
2021NZ$0.83 B25.39%
2020NZ$0.66 B42.98%
2019NZ$0.46 B18.33%
2018NZ$0.39 B51.34%
2017NZ$0.26 B33.04%
2016NZ$0.19 B32.32%
2015NZ$0.14 B23.88%
2014NZ$0.11 B